Comments
Loading...
Corvus Pharma (CRVS) Forecast
NewsEarningsCorvus Pharma (CRVS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Corvus Pharma Stock Price, Quotes and Forecasts | NASDAQ:CRVS | Benzinga
Explore Corvus Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRVS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Corvus Pharma (CRVS) stock?
You can purchase shares of Corvus Pharma (NASDAQ:CRVS) through any online brokerage.
Who are Corvus Pharma (CRVS) competitors?
Other companies in Corvus Pharma’s space includes: Humacyte (NASDAQ:HUMA), Monopar Therapeutics (NASDAQ:MNPR), Tevogen Bio Holdings (NASDAQ:TVGN), Anika Therapeutics (NASDAQ:ANIK) and Eledon Pharmaceuticals (NASDAQ:ELDN).
What is the forecast, or price target, for Corvus Pharma (CRVS) stock?
Corvus Pharma has a consensus price target of $10.80.
What is the current price for Corvus Pharma (CRVS)?
The stock price for Corvus Pharma (NASDAQ: CRVS) is $3 last updated April 14, 2025 at 12:06 PM EDT.
Does Corvus Pharma (CRVS) pay a dividend?
There are no upcoming dividends for Corvus Pharma.
When is Corvus Pharma (NASDAQ:CRVS) reporting earnings?
Corvus Pharma’s Q1 earnings are confirmed for Monday, May 5, 2025.
Is Corvus Pharma (CRVS) going to split?
There is no upcoming split for Corvus Pharma.
What sector and industry does Corvus Pharma (CRVS) operate in?
Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.